调强放射治疗联合周剂量紫杉醇治疗食管癌临床研究.docVIP

调强放射治疗联合周剂量紫杉醇治疗食管癌临床研究.doc

此“医疗卫生”领域文档为创作者个人分享资料,不作为权威性指导和指引,仅供参考
  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
调强放射治疗联合周剂量紫杉醇治疗食管癌临床研究

调强放射治疗联合周剂量紫杉醇治疗食管癌临床研究   [摘要] 目的 探讨紫杉醇单药同步调强放疗治疗食管癌的近期疗效、局部控制率、生存率及毒性反应。 方法 103例食管癌患者根据入选标准分为两组,60例进入调强放疗+紫杉醇组(放化疗组),43例进入单纯调强放疗组(单放组)。单放组采用调强放疗,95%计划靶体积(planning target volume,PTV):66 Gy/30~33次,每周5次;放化疗组:放疗从第1天即开始采用调强放射治疗,同时化疗(紫杉醇30 mg),第1、8、15、22、29、36天静脉滴注。 结果 放化疗组食管癌病灶近期总有效率为83.3%,单放组为60.4%,两组比较差异有统计学意义(P 0.05)。 结论 紫杉醇单药每周方案同步调强放疗治疗食管癌近期疗效和局部控制率较好,能提高远期生存率,虽毒性反应增加但能耐受。   [关键词] 食管癌;紫杉醇;同步放化疗;调强放疗   [中图分类号] R735.1 [文献标识码] A [文章编号] 1673-7210(2012)01(c)-0025-03      Clinical research on Paclitaxel chemotherapy combined with intensity modulated radiation therapy (IMRT) in the treatment of esophageal carcinoma   XIE Zhaohui1 ZHANG Bin2▲ LIU Yanjie1 HUANG Wei1 ZHAN Guanghong1 MA Yongxin1 WANG Wei1   1.Department of Radiation Oncology, Chengde Cancer Hospital, Hebei Province, Chengde 067000, China; 2.CT Room, the Sixth Hospital in Chengde City, Hebei Province, Chengde 067200, China   [Abstract] Objective To evaluate the short-term efficacy, local control rate, survival rate and toxicity of concurrent Paclitaxel chemotherapy combined with IMRT in the treatment of esophageal carcinoma. Methods 103 esophageal carcinoma patients were divided into two groups randomly, 60 cases were treated with concurrent IMRT and Paclitaxel chemotherapy (chemo-radiation group); another 43 cases were treated with radiotherapy only (radiotherapy group). All patients were irradiated by planning target volume (PTV) 95%, five fractions a week, the total radiation dose was 66 Gy/30-33 times in tumor. Besides, the chemo-radiation group was also received the concurrent chemotherapy with 30 mg of Paclitaxel on the 1st, 8th, 15th, 22nd, 29th, 36th day when radiation. Results The chemo-radiation group was more effective than radiotherapy group (83.3% vs 60.4%), and there was significant difference between the two groups (P < 0.05). 1, 2-year survival rates of chemo-radiation group and radiation group were 86.6%, 68.3% and 55.8%, 32.5% respectively, and there was significant difference betwe

文档评论(0)

bokegood + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档